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A B S T R A C T
Despite growing interest in the temporal dynamics of Major Depressive Disorder (MDD), we know little about the
intra-day fluctuations of key symptom constructs. In a study of momentary experience, the Experience Sampling
Method captured the within-day dynamics of negative affect, positive affect, self-esteem, passive suicidality, and
tiredness across clinical MDD (N=31) and healthy control groups (N=33). Ten symptom measures were taken
per day over 6 days (N=2231 observations). Daily dynamics were modeled via intra-day time-trends, varia-
bility, and instability in symptoms. MDD participants showed significantly increased variability and instability in
negative affect, positive affect, self-esteem, and suicidality. Significantly different time-trends were found in
positive affect (increased diurnal variation and an inverted U-shaped pattern in MDD, compared to a positive
linear trend in controls) and tiredness (decreased diurnal variation in MDD). In the MDD group only, passive
suicidality displayed a negative linear trend and self-esteem displayed a quadratic inverted U trend. MDD and
control participants thus showed distinct dynamic profiles in all symptoms measured. As well as the overall
severity of symptoms, intra-day dynamics appear to define the experience of MDD symptoms.
1. Introduction
Recent research has found that dynamics in affect are an integral
part of depression (Houben et al., 2015; Pe et al., 2015). This has led to
calls for affective dynamics to be included in the diagnostic criteria for
Major Depressive Disorder (MDD; Bowen et al., 2013). It would follow
that other MDD symptoms are dynamic in nature, and that these dy-
namics are as important as overall symptom levels or intensity. How-
ever, very little research exists on the within-day dynamics of MDD
symptoms other than affect. This study aims to obtain a descriptive
picture of the daily fluctuations and rhythms of a range of symptom
constructs in MDD.
By its very nature, MDD is a dynamic construct: symptoms are
known to change over time, with MDD episodes fluctuating across re-
mission, pro-dromal, and more clinically severe periods at different
points over months and years (Fried et al., 2016; Iacoviello et al., 2010;
Vergunst et al., 2013). Theory also suggests that depressive symptoms
fluctuate at a more micro-level: for example, cognitive-behavioral as
well as more recent work suggests that depressive symptoms are acti-
vated on a moment-to-moment basis over the course of daily life (Beck
et al., 1979; Wichers, 2014). Alterations in the circadian rhythms of
biological processes such as cortisol and melatonin secretion have also
been found to be associated with depression (Peeters et al., 2003;
Sundberg et al., 2016). Research and theory on the factors underlying
MDD therefore outline inherently dynamic processes that occur within
the context of an individual's everyday life. However, to date, research
on MDD symptoms has relied mostly on measures and diagnostic con-
ceptualizations of MDD that do not capture the daily flow of MDD ex-
perience.
We use the Experience Sampling Method (ESM; Csikszentmihalyi
and Larson, 1987; Stone and Shiffman, 1994) to empirically assess the
intra-day dynamics of five key MDD symptom dimensions (adapted to
the momentary micro-level from macro-level DSM / ICD diagnostic
criteria) in a sample of MDD and healthy control participants. At the
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macro-level, MDD is not a unidimensional construct; rather, it is a
syndrome comprised of heterogeneous symptoms that are distinct
etiologically and have differential effects on biopsychosocial func-
tioning (Fried et al., 2016; Fried and Nesse, 2014). Indeed, an in-depth
symptom-level approach to MDD research has recently been proposed
(Fried and Nesse, 2015). Macro-level symptoms are expressions of
micro-level, moment-to-moment symptom experience (Wichers, 2014).
In the present study, we therefore study micro-level symptoms sepa-
rately, rather than as part of one construct. Alongside positive affect
(PA) and negative affect (NA), the dynamics of self-esteem, tiredness,
and suicidality are explored. These symptoms include cognitive and
affective symptoms, as well as a somatic, non-affective symptom
(tiredness). These symptoms were chosen as the focus of study over
others (e.g. appetite changes, psychomotor symptoms, and concentra-
tion difficulties) because they have been the focus of previous ESM
research. As such, they have all been found to have within-day fluc-
tuations and are known to be subjective experiences that can be studied
effectively with ESM.
1.1. Conceptualizing ‘dynamics’ and their operationalization in affect
This study conceptualizes the temporality of symptoms in three
ways, as: (1) variability in symptom scores across the sampling period;
(2) instability in symptom scores between moments; and (3) systematic
trends in hour-by-hour symptom levels. Below, each conceptualization
is defined and a brief summary is given of how such measures have
been operationalized in relation to affect in MDD.
1.1.1. Defining variability and instability
These concepts are defined comprehensively elsewhere (see Houben
et al., 2015 and Jahng et al., 2008). In short, symptom variability
captures the overall spread of an individual's symptom scores across a
sampling period (i.e. intra-individual variance or standard deviation).
Instability is a more temporally contingent measure, capturing the
frequency and amplitude of symptom fluctuations between moments. It
is the within-person successive difference in between-moment symptom
scores.
1.1.2. Affect variability and instability
The extent to which affect fluctuates during the day is a central part
of subjective emotional experience. In the past decade, a body of re-
search has found that greater variability and instability in NA are re-
lated to poor psychological well-being in general and MDD in particular
(Houben et al., 2015; Wichers et al., 2010).
The relationship between PA instability/variability and MDD is less
clear. In their meta-analysis, Houben et al. (2015) found that although
PA variability/instability was positively associated with poorer psy-
chological health, it was a less powerful predictor of this than NA
variability/instability. Studies on clinical populations have typically
found no significant association between PA variability/instability and
MDD (Peeters et al., 2006; Thompson et al., 2012). Indeed, when the
Houben et al. meta-analysis was confined to studies with clinical po-
pulations, MDD was actually associated with less variability (though not
instability) in PA.
Given that depression is thought to be a dimensional construct
(Prisciandaro and Roberts, 2005), it is not clear why studies have found
that increased PA instability and variability are associated with de-
pressive symptoms in the general population, but not with depression
diagnosis in clinical populations (Gruber et al., 2013; Houben et al.,
2015). Indeed, Houben et al. describe their finding that less variability
in PA is associated with clinical depression as ‘anomalous’, while also
suggesting that less PA variability may reflect the MDD experience of
anhedonia and resulting lack of PA reactivity. The research in that re-
view includes studies using different methodologies (e.g. both ESM and
retrospective measures), different time-scales between reports (be-
tween-day reports and intra-day reports) and different calculations of
variability/instability (e.g. multilevel vs. single level variability/in-
stability analyses). Given these marked methodological and measure-
ment differences, a coherent body of research on intra-day, hour-to-
hour PA variability/instability in MDD has not yet formed. Indeed, the
number of studies that have explored intra-day variability/instability in
affect in MDD remains relatively small. As a result, the nature and re-
lative importance of PA and NA variability and instability in MDD is
unclear. Further research on clinical samples using fine-grained, mul-
tilevel ESM methods is needed to clarify these matters.
1.1.3. Defining diurnal time-trends
Neither variability nor instability directly account for how time it-
self may influence symptom levels. In contrast, the time-trend approach
models symptom severity as a function of time of day. It identifies any
systematic patterns of change in symptom levels across the day. Just as
research on biological circadian rhythms has shown that certain cir-
cadian patterns are associated with disease outcomes (Takahashi et al.,
2008), so too may diurnal rhythms in psychological experience play a
key role in functioning and outcomes in depression.
1.1.4. Diurnal time-trends in affect
Relatively little research exists on diurnal affective rhythms in MDD
(indeed, diurnal time-trends were not included in the Houben et al.
(2015) meta-analysis of affect dynamics). Traditional clinical descrip-
tions of MDD incorporate a ‘morning-worse’ pattern in affect (Hall
et al., 1964; Leibenluft et al., 1992). However, the few studies that have
systematically investigated diurnal time-trends in affect have yielded
conflicting results.
One ESM study found a ‘morning-worse’ pattern in both NA and PA
(Peeters et al., 2006). MDD participants exhibited an inverted U-shaped
pattern in NA with a peak in the mid-morning, while the NA of control
participants did not exhibit a diurnal trend. PA displayed an inverted U-
shaped pattern in both groups. MDD participants, however, showed a
significantly steeper slope in PA over the day, with relatively lower
morning and higher evening levels. These findings are similar to those
of Daly et al. (2011), where individuals with high levels of psycholo-
gical distress had a more pronounced diurnal affective rhythm than
those with low distress levels, characterized by much lower morning PA
and somewhat higher morning NA. In contrast, Murray (2007) found a
less distinct diurnal quadratic rhythm in PA in individuals with high
depression levels compared to those with low depression levels. NA was
not found to have a time-trend in either group. Mata et al. (2012) found
no differences between MDD and control groups in the time-trend of
either NA or PA.
Peeters et al. (2006) is the only study we are aware of that used a
clinical MDD sample in its investigation of time-trends. Mata et al.
(2012) used a community sample that was diagnosed with/without
MDD using structured clinical interviews, while both Murray (2007)
and Daly et al. (2011) used non-clinical samples (indeed, while the PA
time-trend differed across high and low depression scorers in Murray
(2007), mean levels in PA were not significantly different between
groups). The nuances of differences in diurnal patterns of affect may
only be apparent in individuals with clinically more severe MDD. Fur-
ther research on clinical samples is therefore needed to establish a
consensus on the daily affective time-trend of MDD.
1.2. The intra-day dynamics of self-esteem, suicidality, and tiredness in
MDD
Taken together, research on the intra-day dynamics of affect
strongly suggests that dynamic change is a core characteristic of MDD.
It emphasizes the need to move beyond static conceptualizations of
affect, where an individual's average levels are the only aspect con-
sidered. The dynamics revealed by these studies point to increased
emotional fluctuations in MDD and difficulties in regulating daily
subjective experience. It follows that other key MDD symptoms – such
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as self-esteem, suicidality and tiredness – may also be characterized by
specific dynamic patterns. However, as discussed below, research has
continued to focus on absolute levels of these symptoms in MDD and
has not yet considered in detail the nature and pattern of their intra-day
fluctuations.
1.2.1. Self-esteem
Low self-esteem is related to both the aetiology and symptoma-
tology of MDD. The DSM-5 specifies daily feelings of ‘worthlessness’ as
part of its MDD diagnostic criteria, the ICD-10 specifically refers to
‘reduced self-esteem and self-confidence’ in MDD (World Health
Organization, 2010), and most psychological models propose that MDD
is maintained via pervasive negative views of the self (e.g. Beck et al.,
1979). The current study uses the concept of ‘self-esteem’ rather than
the specific symptom of ‘worthlessness’ to allow a comparison with
previous research on self-esteem variability. Items measuring self-es-
teem tend to be more moderately phrased than those that measure
worthlessness, and thus are more likely to detect intra-day variation
(Palmier-Claus et al., 2011).
Prospective studies have consistently found that low self-esteem
predicts depression in clinical and non-clinical samples (Orth et al.,
2008; Rieger et al., 2016; Sowislo and Orth, 2013). A proposed me-
chanism underlying the relationship between low self-esteem and MDD
is self-esteem variability, where relative drops in daily self-esteem
trigger and maintain MDD (Kernis et al., 1998). Cross-sectional work
has found higher levels of day-to-day variability in self-esteem in in-
dividuals currently experiencing depression (Franck and De Raedt,
2007; Sowislo et al., 2014), while prospective studies have found that
such day-to-day self-esteem variability predicts future depression
(Study 2 – Butler et al., 1994; Franck and De Raedt, 2007; Kernis et al.,
1998). However, the strength of the relationship between depression
and self-esteem variability is unclear, as the associations found in some
of these cross-sectional and prospective studies have been weak or non-
significant (Study 1 - Butler et al., 1994; Sowislo et al., 2014).
Previous work on self-esteem variability in MDD has two major
limitations. Firstly, a maximum of two self-esteem measures per day
have been used to derive self-esteem variability (Sowislo et al., 2014;
Kernis et al., 1998). ESM studies on other populations have demon-
strated that self-esteem variability can occur over a much shorter time
frame, from hour-to-hour (Knowles et al., 2007; Thewissen et al., 2011).
No high-frequency ESM study of self-esteem has yet been conducted on
an MDD sample. This is a possible reason for the weak or non-sig-
nificant associations found in some studies: as self-esteem likely fluc-
tuates at a faster rate than day-to-day, studies with low sampling rates
(i.e. one or two measurements per day) may not reliably pick up
variability in this symptom.
A second limitation is that previous research has focused on a single
dimension of self-esteem dynamics: intra-individual variability (stan-
dard deviation) across day-to-day measures. To our knowledge, no re-
search has yet directly investigated the extent of between-moment in-
stability in self-esteem in MDD; rather, previous work has used day-to-
day variability as a proxy for self-esteem instability. Furthermore, re-
search has not yet explored diurnal time-trends in self-esteem in healthy
or MDD populations. The current study thus aims to improve upon
previous literature by (1) using a high-frequency ESM protocol and (2)
studying multiple aspects of self-esteem dynamics to provide a more
nuanced account of self-esteem fluctuations in MDD.
1.2.2. Suicidality
Understanding the dynamics of suicidal ideation is of public health
importance. Lability in suicidality may indicate difficulties in regulating
intrusive suicidal thoughts (indicating suicide risk), while determining
suicidality's diurnal time-course would highlight micro-periods of in-
creased risk for suicide. A small number of previous studies suggest that
micro-level variation is a feature of suicidality. Day-to-day instability in
suicidal ideation has been found to have a stronger association with
previous suicide attempts than duration or intensity of ideation (Witte
et al., 2005, 2006). Furthermore, suicidal behavior has been found to
follow a diurnal course: research on Italian suicide statistics, where
time of death is routinely reported, has found that most suicides take
place in the morning-time (Preti and Miotto, 2001; Williams and
Tansella, 1987).
Little evidence exists on the intra-day dynamics of subjective sui-
cidality. Two studies have investigated the diurnal time-trend of sub-
jective suicidality (Nock et al., 2009; Husky et al., 2014). Contrary to
work on suicidal acts, neither found suicidality to have a significant
time-trend. To our knowledge, no study has yet used ESM to explore
intra-day variability or instability in suicidality.
Previous studies have been limited in their ability to detect within-
day variation in suicidality due to low sampling frequencies (two sig-
nals emitted per day in Nock et al. (2009) and five in Husky et al.
(2014)). They also investigated only one aspect of suicidality: active
suicidal thoughts. These thoughts were found to be relatively rare
(7.8% of reports in Husky et al. (2014) and an intra-individual average
of 1.1 suicidal reports per week in Nock et al. (2009)). Other dimen-
sions of suicidality may be more commonly experienced in daily life.
Passive suicidality deals with vague thoughts of suicide, such as
thoughts of death and feelings that life is not worth living. Having
‘thoughts of death’ is itself part of the DSM-5 criteria for MDD
(American Psychiatric Association, 2013) and such passive suicidality is
associated both with active suicidal ideation and with suicidal acts
themselves (Steer et al., 1993). A high-frequency intra-day measure of
passive suicidal thoughts may therefore allow for a more nuanced
measurement of suicidality in MDD.
1.2.3. Tiredness dynamics
Tiredness is the most prevalent symptom of MDD, with 78% of
patients reporting at least moderate daily levels (Vaccarino et al.,
2008). In healthy individuals, subjective tiredness has a distinctive
diurnal time-trend: a V-shape pattern, where levels decline from
morning to mid-day (where they reach a trough), and then rise steadily
until reaching a peak in the late evening time (Dockray et al., 2010;
Stone et al., 1996, 2006). However, no study has yet investigated the
diurnal dynamics of tiredness in MDD. Given that the diurnal pattern in
tiredness appears to be an integral part of healthy experience, under-
standing how the pattern differs in MDD may provide a new insight into
the nature of this central symptom.
1.3. The present study
Little work has investigated the intra-day dynamics of MDD symp-
toms other than affect. Furthermore, work on affect dynamics has lar-
gely focused on instability and variability, neglecting the importance of
diurnal time-trends in experience. In this study we aimed to extend
prior work by providing a fine-grained ESM account of the within-day
time-trends, instability, and variability of affect, self-esteem, passive
suicidality, and tiredness in MDD. We examined multiple facets of the
intra-day dynamics of affective, cognitive, and somatic symptoms in
tandem in order to improve our overall understanding of the daily ex-
perience of MDD by providing (1) a phenomenological insight into how
symptoms are experienced across the day in MDD and (2) an under-
standing of the differences between psychologically ‘healthy’ and ‘un-
healthy’ patterns of experience, and as such potential targets for
treatment.
Given the lack of previous research, much of this study is ex-
ploratory. For example, we had no specific hypotheses in relation to
self-esteem time-trends or tiredness dynamics in MDD. Nevertheless,
based on the evidence that has been discussed, we hypothesized the
following:
(1) NA, self-esteem, and passive suicidality would exhibit significantly
higher levels of variability and instability in MDD.
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(2) Affect and passive suicidality would exhibit significantly more
pronounced ‘morning-worse’ diurnal time-trends in MDD.
2. Method
2.1. Participants
Participants with MDD were recruited via psychiatric treatment
centers across Dublin, Ireland.2 Individuals attending these centers
were invited to partake if they were currently experiencing an MDD
episode (as per DSM criteria). Control participants were recruited
through an advertisement placed in a national newspaper.3 Controls
were screened via telephone interviews and were not permitted to
partake if they had any psychiatric history. The age range of partici-
pants was 18–70 years. Outpatients and control participants received
reimbursement for travel expenses; there was no other monetary
compensation for participation. Ethical approval was granted from the
relevant ethical review boards.
Participants provided informed consent and then underwent a one-
to-one briefing session with a trained researcher. This involved detailed
instructions on completing the ESM protocol. Participants also com-
pleted the diagnostic Mini International Neuropsychiatric Interview
(MINI Plus 5.0.0, Sheehan et al., 1998), Hamilton Depression Inventory
(Ham-D, Hamilton, 1960), Beck Depression Inventory (BDI, Beck et al.,
1961), Rosenberg Self-Esteem Scale (RSE, Rosenberg, 1965), Beck Scale
for Suicidal Ideation (BSS; Beck et al., 1988), a demographic ques-
tionnaire, and other relevant psychometric assessments (see appen-
dices, which can be viewed online as supplemental material). Case-
consensus conferences with a consultant research psychiatrist and chart
reviews were conducted to verify diagnoses.
2.2. Experience sampling procedure
Following the briefing session, participants underwent 6 con-
secutive days of the ESM. A signal-contingent design was employed,
with a sampling rate of 10 signals per day. This signal frequency al-
lowed a fine-grained analysis of diurnal symptom rhythms and fluc-
tuations between moments, while the spacing of signals captured ex-
periences that spanned the day – morning, afternoon, and evening.
On each ESM day, participants were instructed to go about their
daily activities as normal, while wearing a pre-programmed wristwatch
between the hours of approximately 8 a.m. and 10:30 p.m. During each
of ten 90-min intervals over the day, the wristwatch paged participants.
On hearing the pager, participants were instructed to complete a
2–5min questionnaire on their immediate symptom levels. On the day
following the ESM period, participants underwent a de-briefing session
where they returned their completed ESM materials, which were
checked for validity and rates of completion.
A pen-and-paper ESM was used to facilitate ease of use and open-
ended answers (results of the latter are not included here). With pen-
and-paper ESM modes, there is a risk that surveys could be completed at
a later time and therefore measure retrospective rather than momentary
feelings (Stone et al., 2002). To reduce the likelihood of this, the signal-
contingent pen-and-paper method asks participants to record the cur-
rent time (as per their ESM wristwatch) at the end of each momentary
report. As the time at which participants were paged or ‘beeped’ varied
across hours and days, it was improbable that participants could guess
correctly at a later stage the time at which each beep occurred.
Therefore, responses were validated by matching the self-reported time
of completion of each survey with the pre-programmed time of each
beep. The semi-random design of the signal-contingent ESM paper
mode has been shown to be as valid as computerized versions (Green
et al., 2006; Houben et al., 2015; Palmier-Claus et al., 2011).
2548 momentary surveys were collected. In line with previous ESM
studies on MDD and suicidal samples, responses given outside of 25min
from the time of the signal were excluded from analysis (Peeters et al.,
2006; Husky et al., 2014). Participants who did not provide enough
data to ascertain diurnal trends (at least 30% of reports per day over at
least 2 days) were excluded from the data. These exclusion criteria
resulted in a loss of 313 reports (117 control and 196 MDD reports) and
two individuals (MDD participants) with less than the recommended
number of reports. The remaining sample consisted of 2231 episodes:
1205 control episodes and 1026 MDD episodes.
2.3. ESM measures
The ESM questionnaire was designed to capture key clinical di-
mensions of daily experience in MDD. Each item was measured via a
Likert scale, ranging from 1 (not at all) to 7 (very). Multilevel ex-
ploratory factor analysis with oblique rotation was conducted using
Mplus (version 8). This suggested that the ESM items were measuring
distinctive symptom constructs.
2.3.1. Affect
Items from previous research were used to measure affect (Peeters
et al., 2006; Stone et al., 2006). Individuals were asked to rate their
current levels of ‘happy’, ‘relaxed’, ‘interested’, and ‘enjoying myself’ (PA
items) and ‘irritated’, ‘down’, ‘anxious’, ‘tense’, ‘ashamed,’ and ‘guilty’ (NA
items). Multilevel exploratory factor analysis with oblique rotation on
raw affect scores yielded a two-factor solution according to the Kaiser
criterion (Eigenvalue> 1) at both the between and the within-person
levels. PA item loadings on Factor 1 (PA factor) ranged from 0.78 to
0.99 at the between-person level and 0.43–0.82 at the within-person
level. NA item loadings on Factor 2 (NA factor) ranged from 0.74 to
0.95 at the between-person level and 0.30–0.91 at the within-person
level. NA items were averaged to form an ESM NA score (between-
person composite reliability = 0.84; within-person composite relia-
bility = 0.50), while PA items were averaged to form an ESM PA score
(between-person composite reliability = 0.82; within-person composite
reliability = 0.46). 80.3% / 44.4% of the total between/within-person
variance in the PA items was explained by the PA factor, and 82.9% /
39.5% of the between/within-person variance in NA items was ex-
plained by the NA factor. In line with previous literature, PA and NA
scores appeared to measure separate constructs (Watson and Clark,
1997). Correlations between PA and NA scores were moderate:
r=0.51, p < 0.001 for MDD participants, r=0.59, p < 0.001 for
controls.
2.3.2. Self-esteem
Items by Thewissen et al. (2011) were used to measure self-esteem
in daily-life: ‘I like myself’, ‘I am a good person’, ‘I feel useless’ (reverse-
scored), and ‘I am a failure’ (reverse-scored). Multilevel exploratory
factor analysis with oblique rotation conducted on raw scores of these
items identified one factor with an Eigenvalue> 1. This factor ac-
counted for 71.4% of between-person variance and 31.6% of within-
person variance. The four items had strong loadings (between-person
loadings were 0.82–0.99 and within-person loadings 0.35–0.72). These
items were summed to create the ESM self-esteem measure, with good
reliability (between-person composite reliability = 0.78, within-person
composite reliability = 0.44). Intra-individual means in this ESM self-
esteem item correlated strongly (r=0.87, p < 0.001) with the RSE, a
well-established 10-item scale of global self-esteem level (Rosenberg,
1965).
2.3.3. Suicidality
ESM research has found an aversion effect to extreme or negatively
2 The centers involved in this research were St. John of God's Psychiatric Hospitaller
Services, St. Patrick's University Psychiatric Hospital, St. Vincent's University Hospital
and Glenmalure Community Day Centre in Dublin, Ireland.
3 Irish Times Health Supplement, 2013, February 26th, p. 8.
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valenced items, including those directly assessing active suicidality
(Husky et al., 2014; Nock et al., 2009; Palmier-Claus et al., 2011). With
the aim of obtaining a more nuanced measure of within-day suicidality,
momentary passive suicidality was assessed via the averaged sum of the
more moderately worded items ‘I feel that life is worth living right now’
(reverse scored) and ‘I am having thoughts about death right now’. These
were adapted from similar items in the BSS, a well validated 19-item
self-report of current suicidal ideation (Beck et al., 1988). Participant
mean levels of the ESM passive suicidality item correlated very well
with BSS scores (r=0.63, p < 0.001) and the BDI suicide item
(r=0.63, p < 0.001). This measure was thus designed so as to detect
more variation than extremely negatively valenced items. This strategy
was moderately successful: 85% of MDD reports and 37% of control
reports reported at least some level of passive suicidality (scoring> 1).
Alongside this measure, participants were asked the more negatively
valenced ‘Since the last beep, have you had thoughts about physically
harming yourself in any way?’ to measure directly active suicidal and
self-harm ideation. As expected, this item was endorsed relatively in-
frequently: 3% of all MDD reports answered yes to this question (33
reports in total, nested in 12 individuals), while no control reports
endorsed this item.
2.3.4. Tiredness
In line with previous literature (Stone et al., 2006), tiredness was
seen to be a factor independent of cognitive-affective items, and was
considered as a single item ‘I feel tired’.
2.4. Statistical analysis
As the data had a hierarchical structure, multilevel random-effects
modeling was employed. Independence of data points was not assumed
at the beep or day level, and within- and between-person effects were
estimated simultaneously. Models for each analysis are presented be-
side their corresponding results. All effects were modeled as random
effects (where intercepts and slopes are allowed to vary) using the
“MIXED” command in STATA/SE version 13 (StataCorp). The residual-
error structure used in all models (aside from variability models) was
unstructured covariance, which estimates all associations between error
terms. Robust standard errors were not used in regression analysis, due
to issues with using these on small-moderate samples (Imbens and
Kolesar, 2016). In these models, MDD =group status (a binary variable
where 1=MDD group and 0= control group); i=ESM report/beep
level; j=day level; and k=individual level. β is the fixed regression
coefficient.
3. Results
3.1. Participant characteristics
MDD participants completed an average of 33.1 valid ESM ques-
tionnaires per individual, compared to an average of 36.5 for controls.
The difference between these was non-significant, t(62)= 1.03,
p=0.31. There were no significant differences between MDD and
control groups on most demographic characteristics (see appendix A;
appendices are available to view as online supplemental material). The
exception was gender: there were significantly more females in the
control group. All analyses therefore adjust for gender.
In terms of the MDD group, average scores on the BDI (23) and
Ham-D (18.3) indicated a moderate-severe sample (see Appendix B).
The MDD sample consisted mostly of inpatients (77%; see Appendix C).
However, most inpatients had at least two days leave from hospital
during their ESM week (97%), allowing for a comparison with out-
patient participants. Thirty-three percent of the MDD sample had at-
tempted suicide at least once in the past, while over half (58%) reported
some suicidal ideation. The majority of the MDD participants (89%)
had recurrent depression and 30% had a secondary diagnosis of an
anxiety disorder. Ninety percent of the MDD sample were on anti-de-
pressant medication: 12 individuals were prescribed serotonin-nor-
epinephrine reuptake inhibiters (SNRIs), 10 were prescribed selective
serotonin reuptake inhibiters (SSRIs), 3 were prescribed trycyclics
(TCAs) and 3 atypical antidepressants (e.g. mirtazapine).
3.2. Symptom variability
3.2.1. Between- and within-person variance
Intercept only random-effects models were fitted for each symptom
individually to establish the symptom variance accounted for by be-
tween- and within-person levels. Table 1 presents the intraclass corre-
lation coefficients (ICCs) for each symptom (for example, the ICC for
NA in the total sample is 0.75, meaning that 75% of the variance is at
the between-person level and 25% is at the within-person level; for the
MDD group alone the ICC is 0.66 and for the control group alone the
ICC is 0.53). As shown in Table 1, all ESM symptom measures exhibited
significant between-person variance (Var uk), suggesting significant
variability in all symptoms across the full sample of participants. This
provides evidence against floor and ceiling effects.
3.2.2. Variability
Next, within-person variances for control [var (eikC)] and MDD [var
(eikMDD)] groups were estimated to establish if these differed sig-
nificantly. Random effects models with heteroskedastic errors were
fitted for each symptom (Gutierrez, 2008).4 The intercepts in these
models were fixed so that the only random effect at level 1 was group
(control or MDD). This model is articulated as follows:
= + + + +Symptom β β MDD β Age β Female eik k k k ik0 1 2 3
Where: = − +e e MDD e MDD(1 )ik ikC k ikMDD k
The significance of the difference between control and MDD within-
person variances [var −e e( )ikMDD ikC ] was thus established. As shown in
Table 1, all five symptoms had significantly different variances be-
tween-groups. The MDD group had significantly higher variances in all
symptoms with the exception of tiredness, where the control group had
higher variability (displayed in Fig. 1, row a).
Table 1
Total between-person variance (Var uk), differences between MDD and control within-person variance [Var −e e( )ikMDD ikC ], and Intraclass Correlation Coefficients
(ICCs) for ESM symptom measures for the total sample and for MDD and control groups separately.
Symptom Var uk[95% CI] Var −e e( )ikMDD ikC [95% CI] ICC Total ICC MDD ICC Control
Negative Affect 1.15 [0.96, 1.38] 0.45 [0.39, 0.53] 0.75 0.66 0.53
Positive Affect 1.09 [0.91, 1.30] 0.17 [0.10, 0.29] 0.62 0.50 0.52
Self-Esteem 1.27 [1.06, 1.52] 0.22 [0.19, 0.25] 0.88 0.84 0.63
Suicidality 0.81 [0.68, 0.97] 0.16 [0.13, 0.19] 0.75 0.69 0.50
Tiredness 1.30 [1.09, 1.56] −0.39 [−0.23, −0.68] 0.49 0.45 0.39
4 More information on this model (including STATA commands) can be found at the
following UCLA Statistical Consulting Group webpage: https://stats.idre.ucla.edu/stata/
faq/how-can-i-fit-a-random-intercept-or-mixed-effects-model-with-heteroskedastic-
errors-in-stata/.
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3.3. Symptom instability
To establish symptom instability, successive squared differences
between moments were calculated. These were calculated only on
moments within days; the differences between evening-morning
symptom levels were not included in the analysis. Successive squared
difference values were then square root transformed, so that they re-
flected the size of the absolute change or successive difference (D| |) in
symptom levels between measurement occasions. A two-step regression
analysis was conducted to establish group differences in instability.
Step 1. In this step, MDD group was entered as the predictor vari-
able with gender and age as controls.
= + + + +Symptom D β β MDD β Female β Age e| |ik k k k ik0 1 2 3
Average between-moment symptom fluctuations for MDD and
control participants are displayed in Fig. 1, row b. Estimates from the
multilevel instability analyses are displayed in Table 2. Results from
step 1 were largely as predicted. Significantly higher instability was
found in MDD participants in all symptoms, with the exception of
tiredness where there was no significant difference between groups. NA
instability showed the greatest difference between groups, with fluc-
tuations between moments being almost half a point higher in the MDD
group (B =0.476; SE =0.074; p < 0.001). PA, self-esteem and sui-
cidality all showed between-moment fluctuations that were on average
0.27 – 0.28 points higher in the MDD group (p < 0.001 in each case).
Step 2. In the second step the intra-individual mean of the predictor
symptom was entered as a covariate in the model, as some have
argued that it is important to distinguish symptom instability from
overall severity (Ebner-Priemer et al., 2009):
= + + + +
+
Symptom D β β MDD β MeanLevel β Female β Age
e
| |ik k k k k
ik
0 1 2 3 4
PA and suicidality instability no longer displayed significant asso-
ciations with MDD in this step (p > 0.05; see Table 2). Thus, it appears
that the relationship between instability in these symptoms and MDD
was explained by symptom level. Both NA and self-esteem instability
retained significant associations with MDD when controlling for mean
symptom levels (for NA: B =0.198; SE =0.084; p < 0.02; for self-
esteem: B =0.172; SE =0.073; p < 0.02).
3.4. Diurnal time-trends in symptoms
3.4.1. Modeling time-trends
As quadratic relations have been identified in numerous studies on
the diurnal time-trends of affect in MDD and tiredness in the general
population (e.g. Peeters et al., 2006; Stone et al., 2006), a two-step
approach was used whereby the quadratic term was first tested. We
therefore test whether modeling non-linear trends produces a better fit
to the study data (indicated by a statistically significant quadratic term)
before modeling a linear relationship. Between-group differences in
diurnal trends were investigated by fitting interaction terms between
MDD and the linear (MDD*Time) and quadratic time term
(MDD*Time2). Time-trend effects were then modeled for each group
separately using the below models. Time of day (Time) was treated as a
continuous variable in these time-trend models.
= + + + + +Symptom β β Time β Time β Female β Age eijk ijk ijk k k ijk0 1 2 2 3 4
Where no evidence for a quadratic trend was identified, a linear term
was tested.
= + + + +Symptom β β Time β Female β Age eijk ijk k k ijk0 1 2 3
Fig. 1. Symptom variability (variances; row a) and instability (average symptom fluctuations between moments, the squared root of the successive squared difference
between reports; row b) for MDD and control participants. Error bars are 95% confidence intervals.
Table 2
Association between MDD group status and symptom instability before (step 1)
and after (step 2) adjustment for intra-individual mean symptom levels.
Symptom B SE p
Step 1
Negative Affect |D|
MDD 0.476*** 0.074 < 0.001
Positive Affect |D|
MDD 0.276*** 0.060 < 0.001
Self-Esteem |D|
MDD 0.279*** 0.058 < 0.001
Suicidality |D|
MDD 0.272*** 0.058 < 0.001
Tiredness |D|
MDD 0.100 0.112 0.371
Step 2a
Negative Affect |D|
MDD 0.198** 0.084 0.018
Positive Affect |D|
MDD 0.119 0.078 0.128
Self-Esteem |D|
MDD 0.172** 0.073 0.019
Suicidality |D|
MDD 0.082 0.063 0.193
Tiredness |D|
MDD −0.033 0.137 0.810
All models adjust for age and gender. |D|= Successive difference score between
reports. MDD=binary variable where 1=MDD and 0= control group.
a Includes control for intra-individual mean symptom level.
** p < 0.02.
*** p < 0.001.
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3.4.2. Results
Fig. 2 depicts the diurnal time-trends identified in each group, while
Tables 3 and 4 summarize the findings in relation to these time-trend
regressions. The interaction terms for NA did not reach significance
(p > 0.10), indicating there were no statistically significant differences
between-groups in this diurnal trend. As shown in Table 4, NA did not
display a significant time-trend in either the MDD or control group. PA
and tiredness both showed significant between-group differences in
their diurnal time-trends. In PA, there were significant linear
(B=0.175; SE=0.054; p=0.001) and quadratic (B=−0.016;
SE=0.005; p=0.001) interaction terms, indicating significant differ-
ences between-groups. As shown in Fig. 2, the control group displayed a
linear pattern in PA, which continued to rise from morning through to
late evening. The MDD group displayed an inverted-U (quadratic) PA
time-trend, which rose from morning into the afternoon, before dipping
slightly later in the evening.
Tiredness also displayed significantly different patterns of change
between groups, indicated by the significance of the quadratic inter-
action term (B=−0.015; SE=0.007; p < 0.05). Although the nor-
mative V-shaped quadratic pattern was identified in both MDD and
control groups, the V-shape was significantly more pronounced in the
control group. As seen in Fig. 2, tiredness in MDD had a much flatter
shape over the day.
The linear interaction term for passive suicidality (B=−0.012; SE
=0.007; p < 0.10) and the quadratic interaction term for self-esteem
(B=−0.004; SE=0.003; p < 0.10) were of trend-level significance,
suggesting somewhat different diurnal patterns of change across
groups. As shown in Table 4, group-specific time-trend analyses re-
vealed a significant and negative linear time-trend in suicidality in the
MDD group (B=−0.018; SE =0.006; p < 0.005), but not in the
control group (B=−0.006; SE =0.004; p= 0.089), while there was a
significant quadratic trend in self-esteem in MDD (B =−0.006; SE
=0.002; p= 0.017), but non-significant quadratic and linear trends in
the control group. Thus, as shown in Fig. 2, there was evidence to
suggest a subtle morning peak in passive suicidality levels and inverted-
U diurnal trend in self-esteem in the MDD group.
Fig. 2. Diurnal symptom patterns for MDD and control groups. Row (a) is average raw symptom scores for each time of day for each group. Error bars are 95%
confidence intervals. Row (b) depicts symptom time-trends (regression lines) for control and MDD groups. Y-axis is ESM symptom level (on a Likert scale from 1 to 7).
X-axis is time of day (from 8:30 a.m. to 10:00 p.m.), where each time of day refers to the mid-point of each 90-min ESM ‘beep’ block (each participant was beeped
once during each block).
Table 3
Multilevel estimates of interaction effects between MDD group status (MDD)
and linear and quadratic time of day trends.
Symptom B SE p
Negative Affect
Time*MDD −0.003 0.010 0.765
Time2*MDD – – –
Positive Affect
Time*MDD 0.175** 0.054 0.001
Time2*MDD −0.016** 0.005 0.001
Self-Esteem
Time*MDD 0.062* 0.031 0.045
Time2*MDD −0.004† 0.003 0.095
Tiredness
Time*MDD 0.134 0.084 0.110
Time2*MDD −0.015* 0.007 0.039
Suicidality
Time*MDD −0.012† 0.007 0.078
Time2*MDD – – –
A quadratic model (Time2) was firstly tested. Where no evidence for a quadratic
model was identified a linear model (Time) was tested. Models adjust for
gender and age. Symptoms are measured on a Likert scale from 1 (not at all) to
7 (very). Time is measured in hours and is treated as a continuous variable.
* p < 0.05.
** p < 0.01.
† p < 0.10.
Table 4
Multilevel estimates of linear and quadratic time of day effects on symptoms in
MDD and healthy control groups.
Symptom MDD Healthy Control
B SE p B SE P
Negative Affect
Time −0.009 0.009 0.292 −0.006 0.005 0.175
Time2 – – – – – –
Positive Affect
Time 0.203*** 0.046 <0.001 0.028 0.007 <0.001
Time2 −0.016*** 0.004 <0.001 – – –
Self-Esteem
Time 0.075** 0.029 0.009 −0.003 0.003 0.440
Time2 −0.006* 0.002 0.017 – – –
Tiredness
Time −0.172** 0.061 0.005 −0.304*** 0.057 <0.001
Time2 0.017*** 0.005 0.001 0.032*** 0.005 <0.001
Suicidality
Time −0.018** 0.006 0.003 −0.006 0.004 0.089
Time2 – – – – – –
A quadratic model (Time2) was firstly tested. Where no evidence for a quadratic
model was identified a linear model (Time) was tested. Models adjust for
gender and age. Symptoms are measured on a Likert scale from 1 (not at all) to
7 (very). Time is treated as a continuous variable.
* p < 0.05.
** p < 0.01.
*** p< 0.001.
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4. Discussion
All five symptom constructs displayed distinct intra-day profiles in
MDD when compared to those of healthy controls. Cognitive-affective
symptoms exhibited significantly increased variation in the daily life of
individuals with MDD. In contrast, the one somatic symptom studied,
tiredness, exhibited significantly decreased within-day variation in
MDD. This indicates that as well as the overall severity of symptoms,
symptom dynamics also define the daily experience of MDD and sepa-
rate it from healthy psychological experience.
4.1. Increased variability and instability in cognitive and affective symptoms
Negative affect (NA), positive affect (PA), self-esteem, and passive
suicidality all exhibited large and frequent within-day fluctuations in
the MDD group. In line with a large body of previous work (Houben
et al., 2015), NA showed the greatest difference between groups in
instability and variability. Unlike most previous studies, however, in-
creased instability and variability were also found in PA in MDD (albeit
to a lesser extent than NA). This supports arguments for the importance
of PA dynamics in depression (Gruber et al., 2013). MDD was also
strongly associated with self-esteem variability and instability. This is in
keeping with earlier work on self-esteem variability in MDD (Franck
and De Raedt, 2007) and argues against more recent work positing that
self-esteem variability is not a significant aspect of MDD (Sowislo et al.,
2014). Increased variability and instability in passive suicidality was
another feature of MDD symptom dynamics. Previous work has shown
an association between increased day-to-day instability in suicidality
and past suicide attempts (Witte et al., 2005, 2006). Lability in suicidal
thoughts may therefore prove to be an important factor in under-
standing suicide risk.
The relationship between MDD and symptom instability differed
somewhat across cognitive-affective symptoms. Instability in NA and
self-esteem had strong associations with MDD that were independent of
the severity (mean-levels) of these symptoms. However, mean symptom
levels appeared to explain the relationship between MDD and in-
stability in PA and suicidality: as the severity of daily passive suicidality
increased, so did instability in the intensity of such thoughts, while as
overall PA levels decreased, PA instability increased.
4.2. Diurnal time-trends in positive affect, tiredness, suicidality, and self-
esteem
Diurnal time-trends were identified in PA, tiredness and, to some
degree, passive suicidality and self-esteem. Although NA exhibited high
levels of instability and variability in MDD, it did not display a sig-
nificant diurnal time-trend. This was surprising, as a significant
‘morning worse’ NA trend is a feature of previous conceptualizations of
diurnal mood variation in MDD (Leibenluft et al., 1992; Peeters et al.,
2006). Instead, the morning-worse MDD pattern was manifest in PA.
PA in MDD displayed significantly more diurnal variation than
controls: it had an inverse-U shape (compared to a linear trend in
controls) with a steeper overall increase from morning lows to evening
highs. This pronounced diurnal pattern found in MDD PA is at odds
with the findings of Murray (2007), where depression was associated
with a weakened and flatter diurnal PA pattern. Instead, our findings
replicate the more pronounced quadratic MDD PA pattern found in
Peeters et al. (2006). The finding that ‘morning-worse’ mood in MDD is
expressed via PA lows rather than NA highs is in keeping with recent
research, which also found the ‘morning-worse’ depression pattern to
be much more pronounced in PA than NA (Daly et al., 2011). Again,
this emphasizes the prevalence and importance of PA dynamics in
MDD.
To a lesser extent, suicidality and self-esteem also displayed
morning-worse patterns in MDD. In the MDD group, self-esteem dis-
played an inverse-U shape, but to a much lesser extent than PA. In
suicidality, a significant linear trend with a morning peak was detected
in the MDD group. This is similar to the morning peaks identified in
previous research on suicidal acts (Preti and Miotto, 2001; Williams and
Tansella, 1987). However, the findings in relation to the time-trends of
self-esteem and suicidality should be interpreted with caution: as can be
seen in Fig. 2, both trends were very subtle, and although the trends
were significant in the MDD group, neither were found to be sig-
nificantly different from those of control participants.
Tiredness was uniquely defined by decreased diurnal dynamics in
MDD. The control group had higher variances, a more pronounced V-
shaped diurnal pattern, and a steeper overall increase from morning to
evening levels than the MDD group. Relative to controls, individuals
with MDD experienced tiredness at a high and constant level during the
day, with less of a mid-day nadir in levels. It appears that individuals
with MDD do not feel relatively more tired at night compared to the rest
of their day. This diurnal pattern could help to explain the apparently
paradoxical MDD experience of low levels of daily energy and moti-
vation, yet difficulties in getting to sleep in the evening time.
4.3. Theoretical differences between variability, instability, and diurnal
time-trends
It is important to briefly consider the theoretical differences and
relationships between the dynamics measured, and what they can tell
us about the nature of the symptoms studied. Variability refers to how
much symptoms deviate from average levels over the course of the day.
Variability can be expressed in a number of ways: gradual changes in
symptom levels throughout the day, as well as large changes from one
moment to the next (i.e. instability). Therefore, although the three
concepts measured in this study are related (if an individual has high
instability or a pronounced diurnal time-trend, he/she will also have
high variation from mean levels and thus high variability), they are not
the same thing.
For example, decreased variability – but not instability – was found
in tiredness in the MDD group. It appears that the difference one feels in
tiredness levels from one moment to the next is not as important as a
more gradual variation in overall levels across the day. This gradual
variation in tiredness was expressed as a systematic diurnal time-trend.
This study emphasizes that it is important to measure multiple aspects
of daily symptom dynamics. Variability tells us the extent to which
symptom levels change across the day, while other aspects (instability
and time-trends) give important phenomenological information on how
this variation is experienced.
4.4. Possible mechanisms underlying symptom dynamics
This study's aim was to provide a descriptive account of the dy-
namics of MDD symptom constructs, not to explain why or how these
symptoms fluctuate as they do across the day. Nevertheless, we tenta-
tively suggest two possible mechanisms underlying symptom dynamics:
difficulties in emotion regulation and dysregulation in biological cir-
cadian rhythms.
Common features across cognitive-affective symptoms in MDD are
emotion regulation deficits and a lack of cognitive control (Joormann
and Vanderlind, 2014). Such deficits result in difficulties moderating
cognitive and affective reactions to both external events and internal
thoughts (such as suicidal cognitions and negative self-thoughts), and
could therefore lead to the frequent and amplified fluctuations found in
affect, self-esteem, and suicidality.
The finding that tiredness did not show increased variability or in-
stability in MDD suggests that this symptom is relatively unreactive to
thoughts or external events. Previous work has found that, unlike other
subjective experiences, diurnal variation in tiredness is not dependent
on the activities in which an individual is engaged (Stone et al., 1996,
2006). Instead, tiredness dynamics may be more influenced by en-
dogenous circadian variation in biological systems. The HPA axis plays
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an important role in regulating sleep-wake cycles and energy mobili-
zation and thus influences subjective feelings of fatigue and tiredness
throughout the day (Harris et al., 2015; Tops et al., 2006). A flatter
slope in cortisol output has been identified in individuals with de-
pression (Stetler and Miller, 2005). HPA axis dysregulation could
therefore contribute to the similarly flatter diurnal rhythm found in
MDD tiredness.
Likewise, the MDD ‘morning worse’ diurnal trend in affect has tra-
ditionally been thought to be due to a dysregulation of circardian
rhythms in biological processes, such as HPA axis activity and mela-
tonin secretion (Hall et al., 1964; Moffot et al., 1994). More recent
research has found that morning lows in affect are linked with lower
than average cortisol levels in the hours after waking (Daly et al.,
2011). Experimentally administered cortisol has been found to induce
feelings of energy and vigor (Plihal et al., 1996; Tops et al., 2006).
Energy, alertness, and vigor are aspects of the construct of PA (Watson
and Clark, 1997). Therefore, it makes sense that the affective correlates
of low morning cortisol levels would be expressed via a lack of PA ra-
ther than intense NA – and thus a morning-worse pattern in PA, rather
than NA. Uncovering the mechanisms that underlie MDD symptom
dynamics will be a fruitful area of future research.
4.5. Limitations
This study has a number of limitations. Firstly, the majority of the
MDD sample was receiving pharmacotherapy. Including patients on
medication resulted in a sample that reflects the psychiatric MDD po-
pulation. Nevertheless, it may be the case that the effects of anti-de-
pressant medication drove the group differences in symptom dynamics
found in this study, rather than depression per se. However, research
has found that imipramine reduces the variability of quality of life ESM
reports in individuals with MDD (Barge-Schaapveld and Nicolson,
2002), suggesting that the differences found between groups in the
current study may be even more marked in a non-medicated sample.
Further research is required to establish the differential effect of anti-
depressant treatment on the dynamics of different MDD symptoms.
The MDD sample also consisted of a mix of inpatient and outpatient
participants. We argue that these samples are comparable, since out-
patients were treated at the same facilities as inpatients during the day,
were taking the same medications, and had similar levels of depression.
Additionally, inpatients took at least two days’ leave from their hospital
stay during the ESM week.
The passive suicidality measure has not been used in ESM research
previously. It is therefore unknown whether it is a good proxy for more
active suicidal thoughts and behaviors. However, it correlated strongly
with both BDI and BSS assessments, suggesting that it was tapping into
subjective suicidality. This measure was designed to capture more
variability than negatively valenced suicide items and was endorsed to
a far greater extent than the question directly assessing self-harm and
suicide. However, although 85% of MDD ESM reports and over a third
of control reports reported at least some level of passive suicidality,
controls nevertheless displayed very low scores on this measure, which
may have curtailed the variability that could be identified in this group.
Likewise, the case-control design meant that the control group ex-
hibited much lower NA and much higher self-esteem scores than the
MDD group. As with suicidality, it may be the case that floor and ceiling
effects reduced the ability to detect variation in these symptoms in the
control group. We argue that the results found in these symptoms are
still meaningful because in analyses where mean levels were controlled
for (i.e. instability analysis), significant differences remained across
groups. This indicates that mean levels cannot fully explain the differ-
ences found between MDD and control groups in self-esteem and NA
instability. Nonetheless, a recommendation for further research is to
produce more fine-grained measures of suicidality, NA and self-esteem
that use more items, less negatively worded items and response scales
that allow for small variations to be identified (such as visual analogue
scales). Such measures may be able to detect more variablity in these
symptoms. Including psychiatric as well as healthy control groups may
also allow a more nuanced exploration of daily dynamics in MDD ex-
perience.
4.6. Conclusions and future directions
This study provides a systematic, multidimensional exploration of
five subjectively experienced MDD symptom constructs: PA, NA, self-
esteem, suicidality, and tiredness. We found evidence that the MDD
group differed from the control group across all symptoms investigated,
each of which showed evidence of distinct diurnal time trends and/or
patterns of variability and instability in MDD. This study sets the stage
for additional ESM studies to test these relationships further and ex-
plore the dynamics of an even broader range of MDD experiences and
behavior. Longitudinal designs hold particular promise, as the useful-
ness of this intra-day dynamics approach will ultimately lie in its pre-
dictive power in forecasting diagnoses, treatment, and recovery (van de
Leemput et al., 2014; Wichers et al., 2010).
Individual depression symptoms have recently been found to be
associated with different risk factors, treatment responses, biomarkers
and effects on psychosocial functioning (see review by Fried and Nesse,
2015). Research suggests that different within-day dynamics in affect
also have differential associations with psychological functioning
(Gruber et al., 2013), biological functioning (Daly et al., 2011, 2014;
Peeters et al., 2003) and treatment outcomes (Wichers et al., 2012). It is
likely therefore that dynamics in the other depression symptoms ex-
plored in this study – self-esteem, suicidality and tiredness – also play
distinct roles in MDD outcomes. Broadening the focus of depression
research to include within-day symptom dynamics (alongside symptom
severity) will help us to understand and ultimately treat more effec-
tively the daily experience of MDD.
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